Regencell Bioscience Holdings Limited (RGC) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Regencell Bioscience Holdings Limited, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2350.89x | -9.71x | -51.07x | -60.67x | -98.57x | -163.40x |
| P/B Ratio | 1733.67x | 5.08x | 24.92x | 26.39x | -33.21x | -50.08x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 7.39x | 41.92x | 19.15x | 28.46x | 0.02x | 0.12x |
| Quick Ratio | 7.39x | 41.92x | 19.24x | 28.51x | 0.02x | 0.12x |
| Leverage | ||||||
| Debt/Equity | 0.11x | 0.01x | 0.04x | 0.05x | -0.92x | -1.16x |
YoY = year-over-year change. Source: FMP..